CL2014003297A1 - Use of an anti-inflammatory composition comprising antigenic determinants that are used to prepare a medicament for use against a microbial agent in bone and arthritis (div sol: 244-2013). - Google Patents

Use of an anti-inflammatory composition comprising antigenic determinants that are used to prepare a medicament for use against a microbial agent in bone and arthritis (div sol: 244-2013).

Info

Publication number
CL2014003297A1
CL2014003297A1 CL2014003297A CL2014003297A CL2014003297A1 CL 2014003297 A1 CL2014003297 A1 CL 2014003297A1 CL 2014003297 A CL2014003297 A CL 2014003297A CL 2014003297 A CL2014003297 A CL 2014003297A CL 2014003297 A1 CL2014003297 A1 CL 2014003297A1
Authority
CL
Chile
Prior art keywords
div
arthritis
sol
medicament
bone
Prior art date
Application number
CL2014003297A
Other languages
Spanish (es)
Inventor
Harold David Gunn
Salim Dhanji
Original Assignee
Qu Biolog Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=49118139&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2014003297(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US12/843,296 external-priority patent/US8501198B2/en
Priority claimed from US13/019,208 external-priority patent/US9107864B2/en
Application filed by Qu Biolog Inc filed Critical Qu Biolog Inc
Publication of CL2014003297A1 publication Critical patent/CL2014003297A1/en

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
CL2014003297A 2010-07-26 2014-12-02 Use of an anti-inflammatory composition comprising antigenic determinants that are used to prepare a medicament for use against a microbial agent in bone and arthritis (div sol: 244-2013). CL2014003297A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12/843,296 US8501198B2 (en) 2004-06-07 2010-07-26 Tissue targeted antigenic activation of the immune response to treat cancers
US41137110P 2010-11-08 2010-11-08
US13/019,208 US9107864B2 (en) 2004-06-07 2011-02-01 Tissue targeted antigenic activation of the immune response to treat cancers

Publications (1)

Publication Number Publication Date
CL2014003297A1 true CL2014003297A1 (en) 2015-02-27

Family

ID=49118139

Family Applications (2)

Application Number Title Priority Date Filing Date
CL2013000244A CL2013000244A1 (en) 2010-07-26 2013-01-24 Method for formulating anti-inflammatory composition in a specific organ or tissue comprising an antigenic composition.
CL2014003297A CL2014003297A1 (en) 2010-07-26 2014-12-02 Use of an anti-inflammatory composition comprising antigenic determinants that are used to prepare a medicament for use against a microbial agent in bone and arthritis (div sol: 244-2013).

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CL2013000244A CL2013000244A1 (en) 2010-07-26 2013-01-24 Method for formulating anti-inflammatory composition in a specific organ or tissue comprising an antigenic composition.

Country Status (4)

Country Link
BR (1) BR112013001794B1 (en)
CL (2) CL2013000244A1 (en)
CO (1) CO6680627A2 (en)
ZA (1) ZA201408585B (en)

Also Published As

Publication number Publication date
ZA201408585B (en) 2019-07-31
BR112013001794A2 (en) 2016-05-31
CO6680627A2 (en) 2013-05-31
BR112013001794B1 (en) 2021-11-23
CL2013000244A1 (en) 2013-12-06

Similar Documents

Publication Publication Date Title
CL2011002595A1 (en) Use of a combination of an anticancer agent and an antioxidant to treat cancer; and pharmaceutical composition comprising said combination.
GT201400043A (en) IMIDAZOPIRIDAZINAS REPLACED WITH AMINO
CL2011000935A1 (en) Pharmaceutical composition comprising acetaminophen and a complex tramadol material, which exhibits a sustained and coordinated release through a sustained release and an immediate release layer; method of preparation; and the use of a complex material of tramadol and acetaminophen to prepare a medication for the treatment of pain.
CL2013000063A1 (en) A method of treating a subject comprising administering optionally deuterated n-ethyl-n-phenyl1,2-dihydroxy-4-hodroxy-5-chloro-1-methyl-2-oxoquinoline-3-carboxamide, for the treatment of a disease autoimmune; a mixture thereof; Pharmaceutical composition and its preparation process.
BR112012022797A2 (en) alcohol resistant pharmaceutical composition, and method for treating a disease with an alcohol resistant active agent formulation
PE20140255A1 (en) DISPERSIBLE TABLET IN ORAL FORM
CL2013000098A1 (en) Pharmaceutical composition containing an activated and potentiated formulation of an antibody to the human cannabinoid receptor; methods of use
CL2015002433A1 (en) Imidazopyridazines substituted
BR112014020271A8 (en) PHARMACEUTICAL COMPOSITION AND METHODS TO DECREASE URINATION FREQUENCY IN PATIENTS
CL2012003266A1 (en) Tamarind seed polysaccharide for use in the treatment of microbial infections; pharmaceutical and / or antimicrobial dermocosmetic composition containing said polysaccharide; use of a tamarind seed polysaccharide; method to treat and / or prevent a patient who has a microbial infection.
BR112014016550A8 (en) delayed release formulation to reduce urination frequency and method of use
BR112013004829A2 (en) agricultural chemical dispersing agent composition, agricultural chemical composition, method for producing an agricultural product, method for increasing effectiveness in an agricultural chemical, and use of agricultural chemical dispersing agent composition.
CO6731092A2 (en) New form of encephalinase inhibitor administration
BR112014016661A8 (en) prolonged release formulation to reduce urination frequency and method of use
UY35848A (en) TIENOPIRIMIDINS
CL2013001250A1 (en) Intravenous composition containing ibuprofen and paracetamol combined in defined doses; and use in the treatment of pain and / or inflammation.
BR112015014853A2 (en) PHARMACEUTICAL FORMULATION, LYOPHILIZED PHARMACEUTICAL FORMULATION, USE OF A PHARMACEUTICAL FORMULATION AND ARTICLE OF MANUFACTURE
CL2012003265A1 (en) Tamarind seed polysaccharide for use in the treatment of infectious diseases; pharmaceutical and / or anti-inflammatory dermocosmetic composition containing said polysaccharide; use of a tamarind seed polysaccharide.
CO6660486A2 (en) Topical pharmaceutical or cosmetic composition useful for the treatment of diseases or conditions that present with a deficit of the maturation of the cornea envelope
CL2015001748A1 (en) Transdermic Antiparasitic Formulations
CL2009001841A1 (en) Use of a sustained release composition of 4-aminopyridine to prepare a medicament useful for treating multiple sclerosis in a subject.
BR112013019924A2 (en) oral care compositions
ES2723778T3 (en) Therapy directed at cancer stem cells and against drug-resistant cancer
ECSP12011951A (en) USE OF A SOURCE OF L3 AND / OR L5 AS A VACCINE OR AS A DIAGNOSIS FOR A PARASITARY DISEASE
CL2010001594A1 (en) Use of nifurtimox to prepare a medicine useful in the treatment of diseases caused by trichomonadide.